Keywords: سرطان مثانه; Diffusion-weighted imaging; Genitourinary imaging; Magnetic resonance imaging; Prostate cancer; Bladder cancer; Renal cell carcinoma;
مقالات ISI سرطان مثانه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان مثانه; Renal cancer; Bladder cancer; Prostate cancer; Molecular research; Genitourinary cancer;
Keywords: سرطان مثانه; Bladder cancer; Exercise; Modifiable risk factor; Mortality; Smoking;
Keywords: سرطان مثانه; Bladder cancer; Folate receptor; Tumor behavior; Cancer survival;
Keywords: سرطان مثانه; urinary bladder neoplasms; cystectomy; stents; nephrostomy; percutaneous; neoplasm recurrence; local; BC; bladder cancer; CIS; carcinoma in situ; CSS; cancer specific survival; CT; computerized tomography; IVP; excretory urography; RC; radical cystectomy;
Keywords: سرطان مثانه; cystectomy; length of stay; perioperative care; urinary bladder diseases; urinary bladder neoplasms; ACS NSQIP®; American College of Surgeons National Surgical Quality Improvement Program; ASA®; American Society of Anesthesiologists®; BBC; benign bladd
Keywords: سرطان مثانه; Bladder cancer; Indocyanine green; Lymphadenectomy; Near-infrared fluorescence; Sentinel lymph node biopsy;
Keywords: سرطان مثانه; Bladder cancer; Urothelial carcinoma; Neoadjuvant chemotherapy; Biomarkers; Resistance; Sensitivity;
Keywords: سرطان مثانه; Inorganic arsenic; Meta-regression; Dose-response; Cancer slope factor; Bladder cancer; Lung cancer;
Keywords: سرطان مثانه; Thymol; Bladder cancer; Apoptosis; ROS; MAPKs;
Keywords: سرطان مثانه; Bladder cancer; Immunotherapy; Meta-analysis; Salvage therapy; Urothelial carcinoma;
Keywords: سرطان مثانه; TIL; Immune checkpoint molecules; Immunotherapy; Prostate cancer; Bladder cancer; Testicular tumors;
Keywords: سرطان مثانه; Biomarker; Bladder cancer; Neutrophil-to-lymphocyte ratio; Non-muscle invasive; Prognostic;
Keywords: سرطان مثانه; Bladder cancer; Variable selection; Infrared spectroscopy; Automatic detection; Chalcogenide glass fibers; PLSDA; SVM;
Keywords: سرطان مثانه; PPI; protein-protein interaction; ACTA2; Actin, Alpha 2, Smooth Muscle, Aorta; ACTN1; Actinin, Alpha 1; VCL; Vinculin; CCND1; cyclin D1; MCM7; Minichromosome Maintenance Complex Component 7; TRIM29; Tripartite Motif Containing 29; UBE2C; Ubiquitin-Conjuga
Keywords: سرطان مثانه; Bladder cancer; Intravesical drug delivery; Particulate delivery systems; In situ gelling systems; Mucoadhesive; Floating;
Keywords: سرطان مثانه; Bladder cancer; Epithelial and mesenchymal markers; Metastasis; Pathologic stage and grade; Prognosis;
Keywords: سرطان مثانه; Bladder cancer; Complications; Cystectomy; Pneumonia; Risk factors;
Keywords: سرطان مثانه; Bladder cancer; Finasteride; PLCO;
Keywords: سرطان مثانه; Cryoablation; Bladder cancer; Safety; Efficacy;
Keywords: سرطان مثانه; Smoking; Bladder cancer; Misclassification; Accuracy;
Keywords: سرطان مثانه; Bladder cancer; chemotherapy; intravesical therapy; radical cystectomy; radical radiotherapy; urinary markers
Keywords: سرطان مثانه; Bladder cancer; Bladder stone; Giant cell; Osteoclast-like; Urothelial carcinoma;
Keywords: سرطان مثانه; Bladder cancer; Carboplatin based chemotherapy; Penile metastases; Plasmocytoid variant; Urothelial carcinoma;
Keywords: سرطان مثانه; Bladder cancer; somatic mutations; epigenetics; IKZF1; GOLGA5;
Keywords: سرطان مثانه; Clinical trial; Photodynamic therapy; Bladder cancer; Transurethral resection; Photosensitizer; 5-Aminolevulinic acid;
Keywords: سرطان مثانه; Arginine; Bladder cancer; Radical cystectomy; Myeloid-derived suppressor cells; PG-SGA; Neutrophil:lymphocyte ratio; Fish oil;
Keywords: سرطان مثانه; Bladder cancer; Marital status; Metastasis; Metastasis at diagnosis; SEER;
Keywords: سرطان مثانه; Bladder cancer; Cryoablation; Transurethral resection; Feasibility; Safety;
Keywords: سرطان مثانه; Bladder cancer; Enhanced recovery protocol; Radical cystectomy; Cost analysis;
Keywords: سرطان مثانه; Bladder cancer; Intravesical recurrence; Nephroureterectomy; Upper tract urothelial carcinoma; Lower ureter;
Keywords: سرطان مثانه; Bladder cancer; Histological variant; Immunohistochemistry; Liposarcoma; Pathological diagnosis;
Keywords: سرطان مثانه; Bladder cancer; Race; Survival;
Keywords: سرطان مثانه; Synthetic biology; Bladder cancer; Biomarker; Gene therapy;
Keywords: سرطان مثانه; Bladder cancer; Complications; European; Perioperative outcomes; Radical cystectomy; Readmission;
Keywords: سرطان مثانه; Prostate cancer; Renal cell cancer; Bladder cancer; Germ-cell tumors; Testicular cancer;
Keywords: سرطان مثانه; Malignant stricture; Bladder cancer; Upper tract recurrence; Anastomotic stricture; Urinary diversion;
Keywords: سرطان مثانه; Bladder cancer; Centralization; Lymph node count; Lymph node dissection; Population-based; Staging;
Keywords: سرطان مثانه; Bladder cancer; Frozen section analysis;
Keywords: سرطان مثانه; Bladder cancer; Adenocarcinoma; Tumor location; Prognostic indicators;
Keywords: سرطان مثانه; Bladder cancer; Diabetes; Postoperative complications; Radical cystectomy;
Keywords: سرطان مثانه; OR; odds ratio; CI; confidence interval; TCC; transitional cell carcinoma; G; grade; Bladder cancer; Case-control study; Diet; Dietary water intake; Fluids;
Keywords: سرطان مثانه; Bladder cancer; Alvimopan; CystectomyRC, radical cystectomy; LOS, length of stay; POI, postoperative ileus; RCT, randomized controlled trial; CCS, case–control study; GI, gastrointestinal; CI, confidence intervals
Keywords: سرطان مثانه; Bladder cancer; Radical cystectomy; Transfusion; Hemoglobin; Predictors;
Keywords: سرطان مثانه; Anticoagulant; Antiplatelet; Bladder cancer; Emergency room; Hematuria; Non-muscle invasive bladder cancer
Keywords: سرطان مثانه; TLR4; Bladder cancer; MYD88; TRIF
Keywords: سرطان مثانه; Bladder cancer; Warburg effect; Glucose metabolism
Keywords: سرطان مثانه; urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;
Keywords: سرطان مثانه; Bladder cancer; Open radical cystectomy; Robotic-assisted radical cystectomy; Outcomes; Surgical margins; Lymph node yield;
Keywords: سرطان مثانه; Biomarker; Bladder cancer; Chemotherapy; Computed tomography; Prognosis